EV/EBITDA
-1.08
+0.02+1.82%
Fri, 07 Feb 2025 14:30:00 GMT
Summary
- As of February 8, 2025, AKTX EV/EBITDA is -1.08, with a rise of +0.02 (+1.82%) during the most recent trading day.
- AKTX EV/EBITDA is now -437.50% below its all-time high of 0.32.
Performance
AKTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AKTX EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +1.8% | -1.6% | -1.6% |
1 m1 month | +12.9% | -12.5% | -12.1% |
3 m3 months | - | - | -49.0% |
6 m6 months | +74.7% | -48.8% | -75.2% |
ytdytd | -2.9% | +2.6% | +2.5% |
1 y1 year | - | - | -51.8% |
5 y5 years | +49.1% | -17.9% | -96.6% |
AKTX EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -11.3% | -1.24 | +12.9% | |
3 m | 3-month | -0.82 | -31.7% | -1.95 | +44.6% |
6 m | 6-month | -0.82 | -31.7% | -4.27 | +74.7% |
1 y | 1-year | -0.75 | -44.0% | -4.27 | +74.7% |
3 y | 3-year | -0.16 | -575.0% | -4.69 | +77.0% |
5 y | 5-year | -0.16 | -575.0% | -7.52 | +85.6% |
alltime | all time | 0.32 | -437.5% | -13.49 | +92.0% |
Akari Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -1.08(+2.9%) |
2024 | -1.05(-28.1%) |
2022 | -1.46(-59.4%) |
2021 | -3.60(+13.2%) |
2020 | -3.18(+60.6%) |
Date | Value |
---|---|
2019 | -1.98(+138.6%) |
2018 | -0.83(-23.1%) |
2017 | -1.08(-39.7%) |
2016 | -1.79(-25.7%) |
2015 | -2.41(-44.1%) |
2014 | -4.31 |
FAQ
- What is Akari Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Akari Therapeutics?
- What is AKTX EV/EBITDA year-to-date change?
What is Akari Therapeutics EV/EBITDA?
The current EV/EBITDA of AKTX is -1.08
What is the all time high EV/EBITDA for Akari Therapeutics?
Akari Therapeutics all-time high EV/EBITDA is 0.32
What is AKTX EV/EBITDA year-to-date change?
Akari Therapeutics EV/EBITDA has changed by -0.03 (-2.86%) since the beginning of the year